These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27344157)

  • 21. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
    Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.
    Otowa Y; Nakamura T; Yamamoto M; Kanaji S; Matsuda Y; Matsuda T; Oshikiri T; Sumi Y; Suzuki S; Kakeji Y
    Dis Esophagus; 2017 Dec; 30(12):1-5. PubMed ID: 28881893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer.
    Iwai N; Okuda T; Sakagami J; Harada T; Ohara T; Taniguchi M; Sakai H; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Yasuda H; Naito Y; Itoh Y
    Sci Rep; 2020 Oct; 10(1):18758. PubMed ID: 33127996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma.
    Arima K; Yamashita YI; Hashimoto D; Nakagawa S; Umezaki N; Yamao T; Tsukamoto M; Kitano Y; Yamamura K; Miyata T; Okabe H; Ishimoto T; Imai K; Chikamoto A; Baba H
    Am J Surg; 2018 Jul; 216(1):111-115. PubMed ID: 28859917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer.
    Fujiwara Y; Haruki K; Shiba H; Hamura R; Horiuchi T; Shirai Y; Furukawa K; Gocho T; Yanaga K
    Anticancer Res; 2018 Nov; 38(11):6491-6499. PubMed ID: 30396977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of Pretreatment C-Reactive Protein, Albumin, and C-Reactive Protein to Albumin Ratio in Predicting Poor Prognosis in Epithelial Ovarian Cancer Patients.
    Komura N; Mabuchi S; Shimura K; Kawano M; Matsumoto Y; Kimura T
    Nutr Cancer; 2021; 73(8):1357-1364. PubMed ID: 32835520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma.
    Park HC; Kim MY; Kim CH
    J Korean Assoc Oral Maxillofac Surg; 2016 Oct; 42(5):243-250. PubMed ID: 27847731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer.
    Mao M; Wei X; Sheng H; Chi P; Liu Y; Huang X; Xiang Y; Zhu Q; Xing S; Liu W
    Oncol Lett; 2017 Dec; 14(6):7417-7424. PubMed ID: 29344182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation-based prognostic scores predict disease severity in patients with acute cholecystitis.
    Sato N; Kinoshita A; Imai N; Akasu T; Yokota T; Iwaku A; Koike K; Saruta M
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):484-489. PubMed ID: 29303882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
    Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma.
    Li YJ; Yao K; Lu MX; Zhang WB; Xiao C; Tu CQ
    Onco Targets Ther; 2017; 10():5255-5261. PubMed ID: 29138578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib.
    Lee JM; Lee HS; Hyun JJ; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Um SH; Kim CD
    World J Gastrointest Oncol; 2016 Jul; 8(7):555-62. PubMed ID: 27559435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative high c-reactive protein/albumin ratio is a poor prognostic factor of oral squamous cell carcinoma.
    Wang Q; Song X; Zhao Y; He Q; Shi M; Xu P; Ni S; Chen Y; Lin J; Zhang L
    Future Oncol; 2019 Jul; 15(19):2277-2286. PubMed ID: 31237166
    [No Abstract]   [Full Text] [Related]  

  • 36. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients.
    Hang J; Xue P; Yang H; Li S; Chen D; Zhu L; Huang W; Ren S; Zhu Y; Wang L
    Sci Rep; 2017 Jun; 7(1):2993. PubMed ID: 28592881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.
    Tao CJ; Chen YY; Jiang F; Feng XL; Jin QF; Jin T; Piao YF; Chen XZ
    J Cancer; 2016; 7(14):2005-2011. PubMed ID: 27877215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.
    Inoue D; Ozaka M; Matsuyama M; Yamada I; Takano K; Saiura A; Ishii H
    Jpn J Clin Oncol; 2015 Jan; 45(1):61-6. PubMed ID: 25341546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
    Read JA; Choy ST; Beale PJ; Clarke SJ
    Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Usefulness of Perioperative C-reactive Protein/Albumin Ratio in Patients With Intrahepatic Cholangiocarcinoma: A Retrospective Single Institutional Study.
    Nakao Y; Yamashita YI; Arima K; Miyata T; Itoyama R; Yusa T; Umezaki N; Yamao T; Nakagawa S; Okabe H; Imai K; Chikamoto A; Baba H
    Anticancer Res; 2019 May; 39(5):2641-2646. PubMed ID: 31092463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.